Financhill
Back

ProShares UltraPro S&P500 Vs. Crinetics Pharmaceuticals Industry Stock Comparison

Sell
19

UPRO
ProShares UltraPro S&P500

Last Price:
$85.76
Seasonality Move:
9.33%
Sell
2

CRNX
Crinetics Pharmaceuticals

Last Price:
$40.59
Seasonality Move:
-6.74%
Sell
19
ProShares UltraPro S&P500 (UPRO) is a Sell

Is ProShares UltraPro S&P500 a Buy, Sell or Hold?

  • The current ProShares UltraPro S&P500 [UPRO] share price is $85.70. The Score for UPRO is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • UPRO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
2
Crinetics Pharmaceuticals (CRNX) is a Sell

Is Crinetics Pharmaceuticals a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals [CRNX] share price is $40.59. The Score for CRNX is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

UPRO Stock Price Chart

What is ProShares UltraPro S&P500's stock price today?

  • The ProShares UltraPro S&P500 share price today is $85.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UPRO is experiencing slight selling pressure.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals's stock price today?

  • The Crinetics Pharmaceuticals share price today is $40.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing selling pressure, which indicates risk of future bearish movement.

UPRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.54 Sell
Relative Strength Index (14 RSI): 37.41 Sell
Chaikin Money Flow: -4081638 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (89.59 - 98.35) Sell
Bollinger Bands (100): (81.42 - 94.62) Sell

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.44 Sell
Relative Strength Index (14 RSI): 22.69 Sell
Chaikin Money Flow: -2576687 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.5 - 57.26) Sell
Bollinger Bands (100): (51.08 - 57.64) Sell

UPRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 89.4 Sell
20-day SMA: 92.8 Sell
50-day SMA: 92.89 Sell
200-day SMA: 79.89 Buy
8-day EMA: 89.68 Sell
20-day EMA: 91.74 Sell
50-day EMA: 91.63 Sell
200-day EMA: 80.57 Buy

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.44 Sell
20-day SMA: 52.35 Sell
50-day SMA: 55.3 Sell
200-day SMA: 51.01 Sell
8-day EMA: 48.54 Sell
20-day EMA: 51.52 Sell
50-day EMA: 53.69 Sell
200-day EMA: 49.87 Sell

ProShares UltraPro S&P500 Earnings Growth & UPRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.

ProShares UltraPro S&P500 Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):